These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25091343)

  • 21. A promising method to distinguish vascular dementia from Alzheimer's disease with standardized low-resolution brain electromagnetic tomography and quantitative EEG.
    Wu L; Wu L; Chen Y; Zhou J
    Clin EEG Neurosci; 2014 Jul; 45(3):152-7. PubMed ID: 24214287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive and neuropsychiatric correlates of EEG dynamic complexity in patients with Alzheimer's disease.
    Yang AC; Wang SJ; Lai KL; Tsai CF; Yang CH; Hwang JP; Lo MT; Huang NE; Peng CK; Fuh JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():52-61. PubMed ID: 23954738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantified electroencephalographic correlates of neuropsychological deficits in Alzheimer's disease.
    Pozzi D; Petracchi M; Sabe L; Golimstock A; García H; Starkstein S
    J Neuropsychiatry Clin Neurosci; 1995; 7(1):61-7. PubMed ID: 7711494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Driving cessation and dementia: results of the prospective registry on dementia in Austria (PRODEM).
    Seiler S; Schmidt H; Lechner A; Benke T; Sanin G; Ransmayr G; Lehner R; Dal-Bianco P; Santer P; Linortner P; Eggers C; Haider B; Uranues M; Marksteiner J; Leblhuber F; Kapeller P; Bancher C; Schmidt R;
    PLoS One; 2012; 7(12):e52710. PubMed ID: 23300746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of quantitative EEG between patients with Alzheimer's disease and those with Parkinson's disease dementia.
    Fonseca LC; Tedrus GM; Carvas PN; Machado EC
    Clin Neurophysiol; 2013 Oct; 124(10):1970-4. PubMed ID: 23746496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical sources of resting state electroencephalographic rhythms in Parkinson's disease related dementia and Alzheimer's disease.
    Babiloni C; De Pandis MF; Vecchio F; Buffo P; Sorpresi F; Frisoni GB; Rossini PM
    Clin Neurophysiol; 2011 Dec; 122(12):2355-64. PubMed ID: 21924950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender-Specific Differences in Cognitive Profiles of Patients with Alzheimer's Disease: Results of the Prospective Dementia Registry Austria (PRODEM-Austria).
    Pusswald G; Lehrner J; Hagmann M; Dal-Bianco P; Benke T; Marksteiner J; Mosbacher J; Ransmayr G; Sanin G; Schmidt R
    J Alzheimers Dis; 2015; 46(3):631-7. PubMed ID: 25835423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative EEG findings in different stages of Alzheimer's disease.
    Kwak YT
    J Clin Neurophysiol; 2006 Oct; 23(5):456-61. PubMed ID: 17016157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations of topographical EEG features with clinical severity in mild and moderate dementia of Alzheimer type.
    Chiaramonti R; Muscas GC; Paganini M; Müller TJ; Fallgatter AJ; Versari A; Strik WK
    Neuropsychobiology; 1997; 36(3):153-8. PubMed ID: 9313246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative electroencephalography power and coherence measurements in the diagnosis of mild and moderate Alzheimer's disease.
    Fonseca LC; Tedrus GM; Prandi LR; Andrade AC
    Arq Neuropsiquiatr; 2011; 69(2B):297-303. PubMed ID: 21625754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy.
    Rodriguez G; Vitali P; De Leo C; De Carli F; Girtler N; Nobili F
    Neuropsychobiology; 2002; 46(1):49-56. PubMed ID: 12207147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region and frequency specific changes of spectral power in Alzheimer's disease and mild cognitive impairment.
    Roh JH; Park MH; Ko D; Park KW; Lee DH; Han C; Jo SA; Yang KS; Jung KY
    Clin Neurophysiol; 2011 Nov; 122(11):2169-76. PubMed ID: 21715226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between disease severity and brain electric LORETA tomography in Alzheimer's disease.
    Gianotti LR; Künig G; Lehmann D; Faber PL; Pascual-Marqui RD; Kochi K; Schreiter-Gasser U
    Clin Neurophysiol; 2007 Jan; 118(1):186-96. PubMed ID: 17070733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of quantitative electroencephalography and current source density in patients with Alzheimer's disease.
    Kim JS; Lee SH; Park G; Kim S; Bae SM; Kim DW; Im CH
    Brain Topogr; 2012 Oct; 25(4):461-74. PubMed ID: 22736322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study.
    Riekse RG; Leverenz JB; McCormick W; Bowen JD; Teri L; Nochlin D; Simpson K; Eugenio C; Larson EB; Tsuang D
    J Am Geriatr Soc; 2004 Sep; 52(9):1442-8. PubMed ID: 15341544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer's disease.
    Babiloni C; Lizio R; Del Percio C; Marzano N; Soricelli A; Salvatore E; Ferri R; Cosentino FI; Tedeschi G; Montella P; Marino S; De Salvo S; Rodriguez G; Nobili F; Vernieri F; Ursini F; Mundi C; Richardson JC; Frisoni GB; Rossini PM
    J Alzheimers Dis; 2013; 34(4):1015-35. PubMed ID: 23340039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global approach to multichannel electroencephalogram analysis for diagnosis and clinical evaluation in mild Alzheimer's disease.
    Yoshimura M; Isotani T; Yagyu T; Irisawa S; Yoshida T; Sugiyama M; Minami T; Sugimoto T; Nobuhara K; Okugawa G; Kinoshita T
    Neuropsychobiology; 2004; 49(3):163-6. PubMed ID: 15034231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EEG spectral profile to stage Alzheimer's disease.
    Rodriguez G; Copello F; Vitali P; Perego G; Nobili F
    Clin Neurophysiol; 1999 Oct; 110(10):1831-7. PubMed ID: 10574298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slowing on quantitative spectral EEG is a marker for rate of subsequent cognitive and functional decline in early Alzheimer disease.
    Claus JJ; Kwa VI; Teunisse S; Walstra GJ; van Gool WA; Koelman JH; Bour LJ; Ongerboer de Visser BW
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):167-74. PubMed ID: 9772019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease: relationship between cognitive aspects and power and coherence EEG measures.
    Fonseca LC; Tedrus GM; Prandi LR; Almeida AM; Furlanetto DS
    Arq Neuropsiquiatr; 2011 Dec; 69(6):875-81. PubMed ID: 22297871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.